BioNexus Gene Lab Corp. (BGLC)

USD 2.89

(3.58%)

Revenue Summary of BioNexus Gene Lab Corp.

  • BioNexus Gene Lab Corp.'s latest annual revenue in 2023 was 9.77 Million USD , down -10.6% from previous year.
  • BioNexus Gene Lab Corp.'s latest quarterly revenue in 2024 Q2 was 1.97 Million USD , down -17.1% from previous quarter.
  • BioNexus Gene Lab Corp. reported a annual revenue of 10.92 Million USD in annual revenue 2022, down -18.21% from previous year.
  • BioNexus Gene Lab Corp. reported a annual revenue of 13.36 Million USD in annual revenue 2021, up 17.31% from previous year.
  • BioNexus Gene Lab Corp. reported a quarterly revenue of 2.38 Million USD for 2024 Q1, up 4.79% from previous quarter.
  • BioNexus Gene Lab Corp. reported a quarterly revenue of 2.55 Million USD for 2023 Q3, down -0.51% from previous quarter.

Annual Revenue Chart of BioNexus Gene Lab Corp. (2023 - 2016)

Created with Highcharts 11.1.0YearsRevenue201620172018201920202021202220230 USD5000000 USD10000000 USD15000000 USD

Historical Annual Revenue of BioNexus Gene Lab Corp. (2023 - 2016)

Year Revenue Revenue Growth
2023 9.77 Million USD -10.6%
2022 10.92 Million USD -18.21%
2021 13.36 Million USD 17.31%
2020 11.39 Million USD 8872.03%
2019 126.95 Thousand USD -40.21%
2018 212.32 Thousand USD 97.18%
2017 107.68 Thousand USD 0.0%
2016 - USD 0.0%

Peer Revenue Comparison of BioNexus Gene Lab Corp.

Name Revenue Revenue Difference
Aclaris Therapeutics, Inc. 31.24 Million USD 68.732%
Applied DNA Sciences, Inc. 13.36 Million USD 26.906%
Aspira Women's Health Inc. 9.15 Million USD -6.738%
Biodesix, Inc. 49.08 Million USD 80.095%
bioAffinity Technologies, Inc. 2.53 Million USD -285.817%
bioAffinity Technologies, Inc. 2.53 Million USD -285.817%
Bionano Genomics, Inc. 36.11 Million USD 72.946%
CareDx, Inc 280.32 Million USD 96.514%
Check-Cap Ltd. - USD -Infinity%
Castle Biosciences, Inc. 219.78 Million USD 95.554%
DarioHealth Corp. 20.35 Million USD 51.991%
Exact Sciences Corporation 2.49 Billion USD 99.609%
Fulgent Genetics, Inc. 289.21 Million USD 96.622%
Guardant Health, Inc. 563.94 Million USD 98.267%
ICON Public Limited Company 8.12 Billion USD 99.88%
IDEXX Laboratories, Inc. 3.66 Billion USD 99.733%
Illumina, Inc. 4.5 Billion USD 99.783%
Intelligent Bio Solutions Inc. 3.11 Million USD -213.994%
iSpecimen Inc. 9.92 Million USD 1.585%
Standard BioTools Inc. 106.34 Million USD 90.812%
MDxHealth SA 70.19 Million USD 86.08%
23andMe Holding Co. 219.63 Million USD 95.551%
Medpace Holdings, Inc. 1.88 Billion USD 99.482%
Myriad Genetics, Inc. 678.4 Million USD 98.56%
Mainz Biomed B.V. 895.47 Thousand USD -991.126%
ENDRA Life Sciences Inc. - USD -Infinity%
NeoGenomics, Inc. 591.64 Million USD 98.349%
Neogen Corporation 924.22 Million USD 98.943%
Inotiv, Inc. 572.42 Million USD 98.293%
Natera, Inc. 1.08 Billion USD 99.097%
OpGen, Inc. 3.41 Million USD -185.836%
OPKO Health, Inc. 863.49 Million USD 98.868%
Psychemedics Corporation 22.09 Million USD 55.784%
Prenetics Global Limited 21.74 Million USD 55.062%
Prenetics Global Limited 21.74 Million USD 55.062%
Precipio, Inc. 15.19 Million USD 35.706%
Personalis, Inc. 73.48 Million USD 86.703%
RadNet, Inc. 1.61 Billion USD 99.396%
Sera Prognostics, Inc. 306 Thousand USD -3093.074%
Sotera Health Company 1.04 Billion USD 99.069%
Neuronetics, Inc. 71.34 Million USD 86.305%
Star Equity Holdings, Inc. 45.78 Million USD 78.659%
Star Equity Holdings, Inc. 45.78 Million USD 78.659%
Trinity Biotech plc 56.83 Million USD 82.808%
T2 Biosystems, Inc. 7.19 Million USD -35.838%
Twist Bioscience Corporation 312.97 Million USD 96.878%
Exagen Inc. 52.54 Million USD 81.406%